MedTrace Logo

Routine Electronic Monitoring Of Quality Of Life -Poumon (REMOQOL-Poumon)

NCT04857970 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2021-04-23

No results posted yet for this study

Summary

Routine electronic monitoring of health-related quality of life (REMOQOL) consists of collecting HRQoL patients' data via an electronic device in order to provide these data to healthcare providers. Collected data could be used by professionals to personalize care through for instance, orientation towards personalized supportive care; assessment of toxicities related to treatments or adapted treatments.

The aim of this study is to investigate the impact of REMOQOL on the care relationship in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are naïve for systemic treatment. To do this, the investigators want to conduct a randomized trial at the Besançon University Hospital.

Several teams are collaborating on this project: Methodology and Quality of Life Unit in Oncology (UMQVC), pneumonology and medical oncology services of the Besançon University Hospital and psychology laboratories of Franche-Comté and Burgundy Universities.

The original aspects of this research are the particular interest in the care relationship between physicians and patients, also taking an interest in the physician's experience, the strong collaboration with researchers in psychology, the use of mixed quantitative and qualitative analysis techniques as well as the design of randomized study.

Conditions

Interventions

OTHER

Electronic HRQoL questionnaires with feedback to physicians

Use of the CHES software for HRQoL collection and graphical display of the patients' HRQoL scores to physicians

OTHER

Paper-pencil HRQoL questionnaires w.o. feedback to physicians

Use of paper-pencil HRQoL questionnaires, the results of which are not presented to physicians

Sponsors & Collaborators

  • University of Franche-Comté

    collaborator OTHER

  • University of Burgundy

    collaborator OTHER

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Principal Investigators

  • Virginie WESTEEL, MD PhD · CHU de Besançon

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-20
Primary Completion
2021-11-30
Completion
2025-08-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04857970 on ClinicalTrials.gov